This literature review shows the essence of the problem of extracranial carotid artery stenosis, since this disease is a treatable cause of ischemic stroke and can be reliably detected and assessed by using vascular ultrasound. In Kazakhstan, due to acute disorders of cerebral circulation, 11.1 thousand patients die every year. The reliability of the information in the article was obtained by using the literature data of the last 10 years. The reflection of the criteria for diagnosing stenosis of the extracranial carotid artery, the use of which, in conjunction with standard tests and other sensitive methods, makes it possible to determine the lesion of the extracranial carotid artery at an early stage, as well as a detailed description of diagnostic methods of this complication and evaluation of their effectiveness. Screening for carotid stenosis is important, and whether routine carotid ultrasound is recommended in general population for the prevention of ischemic stroke remains controversial. Screening for carotid stenosis by ultrasound is crucial not only for the daily clinical setting, but also for the management of patients with acute ischemic stroke.
30 December 2022 in BULLETIN OF SURGERY IN KAZAKHSTAN
Critical limb ischemia (CLI) is the final stage of peripheral arterial disease which may lead tothechronic restpain, loss of tissues and limbs. Despite the active development of new technologies, including endovascular and open surgical methods of treatment, and the development of various type of guidelines, CLI still remains an unresolved burden of vascular surgery around the world. In the first part of this review, we described the problem of PAD, in particular, critical lower limb ischemia and the role of diabetes mellitus in the progression of these pathologies. In addition, we tried to reveal the statistics of «small» and «large» amputations in different regions of the world, as well as their social and economic significance.
Stroke is one of the leading causes of death and disability. According to the WHO, mortality due to stroke and other cerebrovascular diseases ranks second after cardiovascular disease. Timely revascularization of the carotid arteries has been shown to be effective in reducing the risk of cerebrovascular accident in patients with symptomatic carotid stenosis of atherosclerotic genesis. However, despite the high efficiency, there are risks of ischemic stroke in the postoperative and long-term period. This review presents statistical data on recurrent strokes and predictors of stroke development after carotid endarterectomy and carotid artery stenting.
Objectives: Hepatocellular carcinoma is the predominant malignancy in patients with cirrhosis and chronic liver disease. Our aim was to assess the morphologic, radiologic, and immunologic characteristics of hepatocellular carcinoma and liver cirrhosis concerning surgical treatment tactics. Materials and Methods: We performed a cross-sectional analysis of a prospective study performed at the JSC National Scientific Center of Surgery (named after A. Syzganov). The study included 58 patients: 31 with hepatocellular carcinoma (53.4%) and 27 with chronic liver disease (46.6%). The average age of patients was 55.6 +/- 1.7 years. Results: Patients were tested for hepatitis B virus and hepatitis C virus infection. Patients with elevated levels of alfa-fetoprotein, alanine aminotransferase, and total bilirubin were detected. Morphologic signs of hepatocellular carcinoma with a predominance of a trabecular type rather than a solid type of tumor were found. Patients with hepatocellular carcinoma underwent surgical liver resection and transarterial chemoembolization before living-donor liver transplant. One-year survival rate of patients with hepatocellular carcinoma was 93.5%. Conclusions: The diagnosis and surgical options for hepatocellular carcinoma should be studied, taking into account the expanded laboratory characteristics of cancer.
30 December 2022 in BULLETIN OF SURGERY IN KAZAKHSTAN
Central venous catheters (CVCs), such as the tunneled catheters and the totally implanted ports, play a major role in general medicine and oncology. Thrombosis associated with CVCs is a common complication in cancer patients. Thus, in order to more widely study the problem of catheter-associated thrombosis in cancer patients, we initiated a study for 2022-2023 within one region. Purpose. Evaluation of the efficacy and safety of thromboprophylaxis of catheter-associated thrombosis with rivaroxaban in cancer patients. Material and methods. Prospective multicenter study, conducted since 01/05/2022 and planned to be completed by the end of 2022, on the basis of three centers. The subjects are divided into 2 groups to randomize 60 participants in each. The first group: receive DOACs (rivaroxaban) at a dosage of 20 mg per day the day before the inserting of the CVC. Second group: treatment of the underlying disease without the use of DOACs. Results. None of the patients developed submassive or massive pulmonary embolism. There were no cases of CAT in the thromboprophylaxis group compared to the non-thrombotic prophylaxis group (0% vs 15.7%). The relative risk of developing CAT is 0.86, which indicates the effectiveness of thromboprophylaxis with rivaroxaban. Conclusion. Our interim results show the efficacy of rivaroxaban at a dosage of 20 mg per day in cancer patients. The final results are planned to be published at the end of the study
1 October 2023 in BULLETIN OF SURGERY IN KAZAKHSTAN
The aim of the study is to determine the levels of the S100B protein in patients with ischemic stroke and evaluate its relationship with the size of brain tissue damage, stroke severity, and clinical outcomes. Materials and methods.The study included 113 patients with acute ischemic stroke, hospitalized within the first day after its onset and subjected to invasive treatment. 101 men and 12 women were examined, including 32 at the age of 50-60, 64 at the age of 61-70, 17 at the age of 71-80. parameters and degree of functional deviations according to the NIHSS scale. Results. The content of S100B during the initial determination on average for the group significantly exceeded the level determined in the control by 3.22 times (p=0.025). There was a direct dependence of the content of S100B on the size of the stroke. A moderate increase in the indicator on the 3rd day relative to the determined one on the 1st day and a decrease on the 7th day after the development of the stroke were revealed. There was no significant dependence of S100B content on the presence of comorbidities. The influence of the studied parameter on the degree of neurological deficit was determined only in patients with a large stroke size.